Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
ACXP

ACXP - Acurx Pharmaceuticals, Inc. Stock Price, Fair Value and News

$2.12-0.04 (-1.85%)
Market Closed

Price Targets

ACXP Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ACXP Price Action

Last 7 days

7.1%

Last 30 days

-45.5%

Last 90 days

-10.5%

Trailing 12 Months

-74.3%

ACXP RSI Chart

ACXP Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ACXP Valuation

Market Cap

6.1M

Price/Earnings (Trailing)

-0.76

Price/Free Cashflow

-0.89

ACXP Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

ACXP Fundamentals

ACXP Earnings

Earnings (TTM)

-8.0M

Earnings Growth (Yr)

43.26%

Earnings Growth (Qtr)

20.8%

ACXP Profitability

Return on Equity

-151.21%

Return on Assets

-103.6%

Free Cashflow Yield

-112.15%

ACXP Investor Care

Shares Dilution (1Y)

146.90%

Diluted EPS (TTM)

-5.47

About Acurx Pharmaceuticals, Inc.

ACXP
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase IIa clinical trial to treat patients with clostridium difficile infections. It is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. The company was incorporated in 2017 and is headquartered in Staten Island, New York.
 CEO
 WEBSITEacurxpharma.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES4

Acurx Pharmaceuticals, Inc. Frequently Asked Questions

ACXP is the stock ticker symbol of Acurx Pharmaceuticals, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri May 01 2026, market cap of Acurx Pharmaceuticals, Inc. is 6.05 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.